SecBot SecBot
8-K ·Filed Oct 26, 2026

MED

MEDIFAST INC
NEUTRAL
Impact 6/10
Processed46m ago SEC0001628280-26-067151
8-K Item 2.02: Earnings release

Price Chart

Loading chart...

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-067151
Document: med-20261026.htm0001628280-26-067151
Document: 0001628280-26-067151-index-headers.html0001628280-26-067151
Document: 0001628280-26-067151-index.html0001628280-26-067151
Document: 0001628280-26-067151.txt0001628280-26-067151
8-K Data (Synthetic)0001628280-26-067151
15 reports for MED
Performance horizon
100% Hit rate @ T+5 4 of 4 directional calls Went positive at some point 4 of 4 best @ T+60▲ +23.89%May 4, 2026
Filters
Rows
Reports for MED — sortable, filterable
TypeNow
Oct 26, 2026
today
8-K
NEUTRAL ★ 6/10
—awaiting T+5——
Oct 15, 2026
11d ago
Press Release
NEUTRAL ★ 2/10
$12.06 $12.17▲ +0.91%▲ +1.93%$11.87 (−1.58%)
Oct 6, 2026
20d ago
Press Release
NEUTRAL ★ 2/10
$11.51 $11.67▲ +1.39%▲ +1.53%$11.87 (+3.13%)
Oct 1, 2026
25d ago
Press Release
NEUTRAL ★ 2/10
$11.43 $11.43· 0.00%▼ −1.30%$11.87 (+3.85%)
Aug 28, 2026
8w ago
Insider Buy
BULLISH ★ 6/10
$12.18 $12.63▲ +3.69%▲ +3.59%$11.87 (−2.55%)
Aug 26, 2026
8w ago
Insider Buy
BULLISH ★ 6/10
$12.22 $12.67▲ +3.68%▲ +3.80%$11.87 (−2.86%)
Aug 21, 2026
9w ago
Insider Buy
BULLISH ★ 6/10
$11.95 $12.18▲ +1.92%▲ +1.45%$11.87 (−0.67%)
Jul 17, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$10.26 $9.45▼ −7.89%▼ −7.21%$11.87 (+15.69%)
Jun 1, 2026
20w ago
8-K
NEUTRAL ★ 2/10
$12.70 $12.10▼ −4.72%▼ −1.97%$11.87 (−6.54%)
May 26, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$12.72 $12.36▼ −2.83%▼ −4.04%$11.87 (−6.68%)
Showing 10 of 15

US Market Status

Market Closed — Opens in 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026

Fresh MED Intelligence

Analysis is for subscribers only.

Medifast reported Q3 2026 revenue of $72.0M, a 19.4% YoY decline, and a GAAP net loss of $17.5M ($1.57/share) vs. a $2.3M loss a year ago. Non-GAAP adjusted net loss was $2.1M ($0.19/share), which beat the consensus estimate of -$0.35.

Subscribe for Full Access